Prenatal antipsychotic exposure and neuromotor performance during infancy

Archives of General Psychiatry

Volumn 69, Issue 8, 2012, Pages 787-794

  Johnson, Katrina C ^a   LaPrairie, Jamie L ^a   Brennan, Patricia A ^a   Stowe, Zachary N ^a,b   Newport, D Jeffrey ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ARIPIPRAZOLE; HALOPERIDOL; HYPNOTIC AGENT; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ARTICLE; BODY POSTURE; CHILD DEVELOPMENT; CHRONICITY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HABITUATION; HUMAN; INFANCY; INFANT; MAJOR CLINICAL STUDY; MALE; MOTOR NEURON DISEASE; MOTOR PERFORMANCE; MUSCLE TONE; NEUROLOGIC EXAMINATION; NEUROMUSCULAR FUNCTION; PRENATAL EXPOSURE; PROSPECTIVE STUDY; PSYCHOSIS; PUERPERAL DEPRESSION; PUERPERIUM; REFLEX; TASK PERFORMANCE; VISUAL SYSTEM EXAMINATION;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CHILD DEVELOPMENT; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HABITUATION, PSYCHOPHYSIOLOGIC; HUMANS; INFANT; LONGITUDINAL STUDIES; MATERNAL EXPOSURE; NEUROPSYCHOLOGICAL TESTS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOMOTOR PERFORMANCE; PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS; RISK ASSESSMENT;

EID: 84865559194     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2012.160     Document Type: Article

References (46)

1. Nicholson J, Biebel K, Katz-Leavy J, Williams V. The Prevalence of Parenthood in Adults With Mental Illness: Implications for State and Federal Policymakers, Programs and Providers. Boston: University of Massachusetts Medical School; 2002.
2. Grof P, Robbins W, Alda M, Berghoefer A, Vojtechovsky M, Nilsson A, Robertson C. Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J Affect Disord. 2000;61(1-2):31-39.
3. Freeman MP, Smith KW, Freeman SA, McElroy SL, Kmetz GE, Wright R, Keck PE Jr. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry. 2002;63(4):284-287. (Pubitemid 34456354)
4. Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, Zurick A, Cohen LS. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007;164(12):1817-1824. (Pubitemid 351739234)
5. Newport DJ, Stowe ZN, Viguera AC, Calamaras MR, Juric S, Knight B, Pennell PB, Baldessarini RJ. Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disord. 2008;10(3):432-436. (Pubitemid 351522668)
6. Casiano ME, Hawkins DR. Major mental illness and childbearing: a role for the consultation-liaison psychiatrist in obstetrics. Psychiatr Clin North Am. 1987;10(1):35-51. (Pubitemid 17049095)
7. Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, Suri R, Burt VK, Hendrick V, Reminick AM, Loughead A, Vitonis AF, Stowe ZN. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295(5):499-507. (Pubitemid 43200344)
8. Kuehn BM. Questionable antipsychotic prescribing remains common, despite serious risks. JAMA. 2010;303(16):1582-1584.
9. Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS. Increasing off-label use of antipsychotic medications in the United States, 1995-2008. Pharmacoepidemiol Drug Saf. 2011;20(2):177-184.
10. McKenna K, Einarson A, Levinson A, Gideon K. Significant changes in antipsychotic drug use during pregnancy. Vet Hum Toxicol. 2004;46(1):44-46. (Pubitemid 38095889)
11. McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O, Levinson A, Zipursky RB, Einarson A. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. J Clin Psychiatry. 2005;66(4):444-449. (Pubitemid 40593572)
12. Newport DJ, Calamaras MR, DeVane CL, Donovan J, Beach AJ, Winn S, Knight BT, Gibson BB, Viguera AC, Owens MJ, Nemeroff CB, Stowe ZN. Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry. 2007;164(8):1214-1220. (Pubitemid 47292410)
13. Newham JJ, Thomas SH, MacRitchie K, McElhatton PR, McAllister-Williams RH. Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study. Br J Psychiatry. 2008;192(5):333-337. (Pubitemid 351692376)
14. Babu GN, Desai G, Tippeswamy H, Chandra PS. Birth weight and use of olanzapine in pregnancy: a prospective comparative study. J Clin Psychopharmacol. 2010;30(3):331-332.
15. Koren G, Cohn T, Chitayat D, Kapur B, Remington G, Reid DM, Zipursky RB. Use of atypical antipsychotics during pregnancy and the risk of neural tube defects in infants. Am J Psychiatry. 2002;159(1):136-137. (Pubitemid 41070740)
16. Reis M, Källén B. Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol. 2008;28(3):279-288.
17. Bazire S. Psychotropic Drug Directory. Salisbury, England: Five-pin Limited; 2005.
18. Biswasl PN, Wilton LV, Pearcel GL, Freemantle S, Shakir SAW. The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. J Psychopharmacol. 2001;15(4):265-271. (Pubitemid 34024244)
19. Goldstein DJ, Corbin LA, Fung MC. Olanzapine-exposed pregnancies and lactation: early experience. J Clin Psychopharmacol. 2000;20(4):399-403. (Pubitemid 30463754)
20. Auerbach JG, Hans SL, Marcus J, Maeir S. Maternal psychotropic medication and neonatal behavior. Neurotoxicol Teratol. 1992;14(6):399-406. (Pubitemid 23008806)
21. Gentile S. Antipsychotic therapy during early and late pregnancy: a systematic review. Schizophr Bull. 2010;36(3):518-544.
22. Costa LG, Steardo L, Cuomo V. Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects. Pharmacol Rev. 2004;56(1):103-147. (Pubitemid 38314581)
23. Rosengarten H, Quartermain D. Effect of prenatal administration of haloperidol, risperidone, quetiapine and olanzapine on spatial learning and retention in adult rats. Pharmacol Biochem Behav. 2002;72(3):575-579. (Pubitemid 34460487)
24. Zuo J, Liu Z, Ouyang X, Liu H, Hao Y, Xu L, Lu X-H. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(2):387-397. (Pubitemid 351187831)
25. Newport DJ, Brennan PA, Green P, Ilardi D, Whitfield TH, Morris N, Knight BT, Stowe ZN. Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation. BJOG. 2008;115(6):681-688. (Pubitemid 351514588)
26. Brennan PA, Pargas R, Walker EF, Green P, Newport DJ, Stowe Z. Maternal depression and infant cortisol: influences of timing, comorbidity and treatment. J Child Psychol Psychiatry. 2008;49(10):1099-1107.
27. Ellison PH, Horn JL, Browning CA. Construction of an Infant Neurological International Battery (INFANIB) for the assessment of neurological integrity in infancy. Phys Ther. 1985;65(9):1326-1331. (Pubitemid 15235176)
28. Einarsson-Backes LM, Stewart KB. Infant neuromotor assessments: a review and preview of selected instruments. Am J Occup Ther. 1992;46(3):224-232.
29. Soleimani F, Dadkhah A. Validity and reliability of Infant Neurological International Battery for detection of gross motor developmental delay in Iran. Child Care Health Dev. 2007;33(3):262-265. (Pubitemid 46592539)
30. Fagen JW, Ohr PS. Learning and Memory in Infancy: Habituation, Instrumental Conditioning and Expectancy Formation. Biobehavioral Assessment of the Infant. New York, NY: The Guilford Press; 2001:233-273.
31. McCall RB, Carriger MS. A meta-analysis of infant habituation and recognition memory performance as predictors of later IQ. Child Dev. 1993;64(1):57-79.
32. Columbo J. Infant Cognition: Predicting Later Intellectual Functioning. Thousand Oaks, CA: Sage Publications, Inc; 1993.
33. Bornstein MH. Habituation of attention as ameasure of visual information processing in human infants: summary, systematization, and synthesis. In: Gottlieb G, Krasnegor NA, eds. Measurement of Audition and Vision in the First Year of Postnatal Life: A Methodological Overview. Westport, CT: Ablex Publishing; 1985:253-300.
34. Lobbestael J, Leurgans M, Arntz A. Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II). Clin Psychol Psychother. 2011;18(1):75-79.
35. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8(1):77-100. doi:10.1016/0272-7358(88)90050-5. (Pubitemid 18045797)
36. Ji S, Long Q, Newport DJ, Na H, Knight B, Zach EB, Morris NJ, Kutner M, Stowe ZN. Validity of depression rating scales during pregnancy and the postpartum period: impact of trimester and parity. J Psychiatr Res. 2011;45(2):213-219.
37. Voorn P, Kalsbeek A, Jorritsma-Byham B, Groenewegen HJ. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience. 1988;25(3):857-887.
38. Scalzo FM, Spear LP. Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats. Psychopharmacology (Berl). 1985;85(3):271-276. (Pubitemid 15123098)
39. Scalzo FM, Holson RR, Gough BJ, Ali SF. Neurochemical effects of prenatal haloperidol exposure. Pharmacol Biochem Behav. 1989;34(4):721-725. (Pubitemid 20036567)
40. Brooks DJ. Functional imaging studies on dopamine and motor control. J Neural Transm. 2001;108(11):1283-1298. (Pubitemid 33141303)
41. Herlenius E, Lagercrantz H. Neurotransmitters and neuromodulators during early human development. Early Hum Dev. 2001;65(1):21-37. (Pubitemid 32743368)
42. Cases O, Lebrand C, Giros B, Vitalis T, De Maeyer E, Caron MG, Price DJ, Gaspar P, Seif I. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs. J Neurosci. 1998;18(17):6914-6927. (Pubitemid 28388021)
43. Sodhi MSK, Sanders-Bush E. Serotonin and brain development. Int Rev Neurobiol. 2004;59:111-174. (Pubitemid 39752414)
44. Vinay L, Ben-Mabrouk F, Brocard F, Clarac F, Jean-Xavier C, Pearlstein E, Pflieger J-F. Perinatal development of the motor systems involved in postural control. Neural Plast. 2005;12(2-3):131-139, discussion 263-272.
45. Dannemiller JL. Infant habituation criteria: a Monte Carlo study of the 50% decrement criterion. Infant Behav Dev. 1984;7(2):147-166. doi:10.1016/S0163-6383(84)80055-7.
46. Columbo J. What habituates in infant visual habituation? a psychophysiological analysis. Infancy. 2010;15(2):107-124. doi:10.1111/j.1532- 7078.2009.00012.x.